Skip to main content

Laura J Van't Veer

NIH Rank #8770
  • Program Leader
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10469779Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Pathology

NIH Funding · FY2025

Linked Award Amount
$1.7M
Full award amounts, FY2025
Award Records
3
Records listing this PI
Award-Linked Rank
#8,770
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Laura J Van't Veer. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Laura J Van't Veer as a PI. Multi-PI records show the full award amount for context.

  • 5P01CA281826-02P01
    WISDOM: A platform to optimize subtype-specific screening and prevention
    $733.3K
    award amount
  • 5R01CA255442-05R01
    Strategy for combining circulating tumor DNA (ctDNA) and magnetic resonance imaging (MRI) measures of tumor burden for prediction of response and outcome in neoadjuvant-treated early breast cancer
    $670.2K
    award amount
  • 5P01CA210961-08P01
    The I SPY 2.2 TRIAL: Evolving to Imaging and Molecular Biomarker Response Directed Adaptive Sequential Treatment to Optimize Breast Cancer Outcomes
    $257.5K
    award amount

Award organization

Organizations that administered FY2025 awards listing Laura J Van't Veer as a PI.

FY2025 award administered by University of California, San Francisco (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    University of California, San Francisco
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #7942
  5. 2025
    $2M Cumulative Funding
  6. 2025
    R01 Grant Holder
  7. 2025
    Program/Center Grant Leader